Transparency
We believe that transparency is key to building and maintaining confidence and trust in us, and in our medicines. Our relationship with healthcare professionals (HCPs) and healthcare organisations (HCOs) plays a vital role in the development and delivery of medicines. We want to ensure that patients and others have confidence that this relationship is open and transparent.
Our transfers of value to individual healthcare professionals and healthcare organisations from 2015, have been submitted to the ABPI disclosure database and IPHA disclosure website.
Patient Organisation Disclosure
Disclosure 2022
|
Year |
Patient Organisation Recipient Name |
Amount |
Purpose |
|
2022 |
National Eczema Society |
£24,000 |
Corporate membership / sponsorship |
Disclosure 2021
|
Year |
Patient Organisation Recipient Name |
Amount |
Purpose |
|
2021 |
Burma Skincare Initiative |
£10,000 |
Myanmar Grant Application |
|
2021 |
Psoriasis Association |
£3,000 |
Corporate Membership of the Psoriasis Association |
Disclosure 2020
|
Year |
Patient Organisation Recipient Name |
Amount |
Purpose |
|
2020 |
National Eczema Society |
£3,275 |
Activity Support - 2 laptops |
|
2020 |
Psoriasis Association |
£5,000 |
COVID-19 support |
|
2020 |
Psoriasis Association |
£1,500 |
Corporate Membership of the Psoriasis Association |
|
2020 |
The All Party Parliamentary Group on Skin (APPGS) |
£2,400 |
Financial support to support dermatology related activities |
|
2020 |
MS Ireland |
Euro 7000 |
Support towards MS survey |